{
    "code": "60001040",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001040",
    "time": "2021-03-12 03:13:43",
    "許可證字號": "衛部菌疫輸字第001040號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/02\/23",
    "發證日期": "106\/02\/23",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000104009",
    "中文品名": "百利妥注射劑",
    "英文品名": "BLINCYTO for Injection",
    "適應症": "1.1\t微量殘留病灶 (MRD) 陽性 B 細胞前驅細胞之急性淋巴芽細胞白血病 (ALL)\r\nBLINCYTO 適用於治療第一次或第二次完全緩解後仍有大於或等於0.1%微量殘留病灶 (MRD)之 B 細胞前驅細胞急性淋巴芽細胞白血病 (ALL)。\r\n1.2\t復發型或頑固型 B 細胞前驅細胞之急性淋巴芽細胞白血病 (ALL)\r\nBLINCYTO 適用於治療復發型或頑固型 B 細胞前驅細胞之急性淋巴芽細胞白血病 (ALL) 。",
    "劑型": "243凍晶注射劑",
    "包裝": "100支以下盒裝(type I glass)小瓶裝 IV溶液穩定劑10mL(type I glass)小瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "111\/02\/23",
    "主成分略述": "blinatumomab",
    "限制項目": "02輸　入 1D須執行風險管理計畫 1S須執行確認性療效臨床試驗 5F免除銜接性試驗",
    "申請商名稱": "620117N253  台灣安進藥品有限公司",
    "申請商地址": "臺北市信義區松仁路100號13樓之1、之2",
    "主製造廠": [
        {
            "製造廠名稱": "FDE0021300  BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG",
            "製造廠廠址": "BIRKENDORFER STRASSE 65, 88397 BIBERACH AN DER RISS.  GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "成品製造廠"
        },
        {
            "製造廠名稱": "FIE0040100  Amgen Technology (Ireland) Unlimited Company",
            "製造廠廠址": "Pottery Road, Dun Laoghaire, Co., Dublin, Ireland",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": "成品製造廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FGB0385100  LONZA BIOLOGICS PLC",
            "製造廠廠址": "228 BATH ROAD, SLOUGH, BERKSHIRE, SL1 4DX, UNITED KINGDOM",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FPR0034000  AMGEN MANUFACTURING,LIMITED",
            "製造廠廠址": "STATE ROAD 31,KM 24.6 JUNCOS,PUERTO RICO 00777-4060",
            "製造廠公司地址": "",
            "製造廠國別": "PUERTO RICO",
            "製程": "包裝"
        }
    ],
    "CCC號列": "30021500005 免疫產品，具有劑量或零售包裝式樣者Immunological products, put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013006200",
            "成分名稱": "blinatumomab",
            "含量描述": "",
            "含量": "35.0000000000",
            "單位": "ug"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Blincyto_20170615_Vial 1-106-06-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001040&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Blincyto 中文仿單TWBLIPI05_Jul2020-109-09-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001040&Seq=005&Type=9"
        },
        {
            "title": "BLINCYTO_20180911_Label VI 35mcg (廠商自行上傳)-108-07-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001040&Seq=011&Type=8"
        },
        {
            "title": "BLINCYTO_20180911_Carton (廠商自行上傳)-108-07-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001040&Seq=010&Type=8"
        },
        {
            "title": "Blincyto_20170615_Carton 6-106-06-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001040&Seq=009&Type=8"
        },
        {
            "title": "Blincyto_20170615_Carton 5-106-06-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001040&Seq=008&Type=8"
        },
        {
            "title": "Blincyto_20170615_Carton 4-106-06-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001040&Seq=007&Type=8"
        },
        {
            "title": "Blincyto_20170615_Carton 3-106-06-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001040&Seq=006&Type=8"
        },
        {
            "title": "Blincyto_20170615_Carton 2-106-06-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001040&Seq=005&Type=8"
        },
        {
            "title": "Blincyto_20170615_Carton 1-106-06-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001040&Seq=004&Type=8"
        },
        {
            "title": "BLINCYTO標籤MCK4703 ART LBL VI 35 mcg 103-106-03-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001040&Seq=003&Type=8"
        },
        {
            "title": "BLINCYTO外盒1015593 ART CRTN DP VI 35 mcg 103-106-03-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001040&Seq=002&Type=8"
        },
        {
            "title": "BLINCYTO IVSS標籤MCK4704 ART LBL VI 0mcg 103-106-03-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001040&Seq=001&Type=8"
        }
    ]
}